alunbrig
takeda pharma a/s - brigatinib - karcinóm, pľúc bez malých buniek - antineoplastické činidlá - alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase alkpositive advanced nsclc previously treated with crizotinib.
vyxeos liposomal (previously known as vyxeos)
jazz pharmaceuticals ireland limited - daunorubicin hydrochloride, cytarabine - leukémia, myeloidná, akútna - antineoplastické činidlá - vyxeos liposomal je indikovaný na liečbu dospelých pacientov s novo diagnostikovanou, terapie, súvisiace s akútna myeloidná leukémia (t-aml) alebo aml s myelodysplasia zmeny týkajúce sa (aml-mrk).
paricalcitol pharmathen 5 mikrogramov/ml
pharmathen s.a., grécko - parikalcitol - 87 - varia i
paricalcitol pharmathen 2 mikrogramy/ml
pharmathen s.a., grécko - parikalcitol - 87 - varia i
pramipexol teva pharma 2,62 mg
teva pharmaceuticals slovakia s.r.o., slovensko - pramipexol - 27 - antiparkinsonica
pramipexol teva pharma 2,1 mg
teva pharmaceuticals slovakia s.r.o., slovensko - pramipexol - 27 - antiparkinsonica
pramipexol teva pharma 1,05 mg
teva pharmaceuticals slovakia s.r.o., slovensko - pramipexol - 27 - antiparkinsonica
pramipexol teva pharma 0,52 mg
teva pharmaceuticals slovakia s.r.o., slovensko - pramipexol - 27 - antiparkinsonica
pramipexol teva pharma 0,26 mg
teva pharmaceuticals slovakia s.r.o., slovensko - pramipexol - 27 - antiparkinsonica
paracetamol/kofein dr. müller pharma 1000 mg/130 mg tablety
dr. müller pharma s.r.o., Česká republika - paracetamol, kombinácie s výnimkou psycholeptík - 07 - analgetica, antipyretica